Indberetningsfrekvensen for rabdomyolyse i forbindelse med cerivastatin er højere end for andre statiner, og imod forventning er den steget med tiden.
The reporting rate for rhabdomyolysis with cerivastatin is higher than with other statins and contrary to expectations has increased over time.